The Role of Risk Evaluation in Minimizing Recurrence and Metastasis in Patients with cSCC Undergoing Surgical Intervention

Released On
September 1, 2020

Expires On
September 1, 2021

Media Type

Completion Time
60 minutes

Dermatology, Hematology-Oncology

Scroll to the Bottom of this Information to Begin this Course

Jointly provided by Med Learning Group and Ultimate Medical Academy/CCM.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 ANCC Contact Hour

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of surgical dermatologists, Mohs surgeons, surgical oncologists, dermatologists, and other healthcare practitioners who care for patients with advanced or metastatic cutaneous squamous cell carcinoma.

Program Overview

This enduring activity is focused on the management of patients with advanced or metastatic cutaneous squamous cell carcinoma.

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Compare the relative effectiveness of tumor staging systems for the identification of patients with cutaneous squamous cell carcinoma (cSCC) at high-risk of recurrence or metastasis
  • Utilize tumor staging and risk evaluation to stratify candidates for Mohs micrographic surgery, standard excision, or nonsurgical interventions and discuss the benefits and risks of each therapeutic option
  • Evaluate guidelines for surgical and pharmacologic treatment of cSCC based on clinical trial data
  • Identify patients with unresectable cSCC who would benefit from targeted systemic therapy


Gregory A Daniels, MD, PhD

Medical Oncologist
Professor of Medicine
Moores Cancer Center
UC San Diego Health
La Jolla, CA

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

Credit Designation

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Purpose: This program would be beneficial for nurses involved in the care of patients with advanced or metastatic cutaneous squamous cell carcinoma.
Credits: 1.0 ANCC Contact Hour.

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosures of Conflicts of Interest

Gregory A Daniels, MD, PhD, discloses that he is on the speakers’ bureau for Sanofi and Regeneron Pharmaceuticals, Inc.

CME Content Review

The content of this activity was independently peer reviewed.

The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse. The reviewer has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Melissa A Johnson, Sr. Program Manager of Med Learning Group, has nothing to disclose.
Marcello A. Morgan, MD, MPH, Medical Director of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CME/CNE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Method of Participation

There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the enduring activity.
  3. Complete pre-and-post surveys and evaluation.


Med Learning Group makes every effort to develop CME activities that are scientifically based.

This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making experience before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at

Americans with Disabilities Act

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.